Investment Focus & Approach
SR One invests globally in early stage healthcare companies pursuing innovative, breakthrough science. Our expanded remit also focuses on accessing technology innovations from throughout GSK to create new value by using these inventions for other products and in other industries. Overall, we look for investments that can provide attractive financial returns and significant strategic value.
How We Work
We seek global investment opportunities in the life science sectors, and prefer to be the lead or co-lead investor. We will also actively participate in opportunities as part of a syndicate. We are aligned with other financial investors and do not ask for specific product rights or options. We are active investors and typically take board of directors or board observer seats. We also maintain a strict firewall with GSK on confidential items received from a portfolio company or an investment opportunity under review by our team.